Tong, Weilin <br/><br/>
Foam Cell-Derived CXCL14 Muti-Functionally Promotes Atherogenesis and Is a Potent Therapeutic Target in Atherosclerosis.  [electronic resource] 

 -  Journal of cardiovascular translational research  04 2020 
 - 215-224 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1937-5395 
<br/><br/><label>Standard No.: </label>10.1007/s12265-019-09915-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Atherosclerosis--immunology<br/>Binding Sites<br/>Chemokines, CXC--genetics<br/>Disease Models, Animal<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Foam Cells--immunology<br/>Humans<br/>Macrophages, Peritoneal--immunology<br/>Male<br/>Mice, Inbred C57BL<br/>Mice, Knockout, ApoE<br/>Middle Aged<br/>Peptide Fragments--administration & dosage<br/>Plaque, Atherosclerotic<br/>Promoter Regions, Genetic<br/>Signal Transduction<br/>THP-1 Cells<br/>Transcription Factor AP-1--metabolism<br/>Up-Regulation<br/>Vaccines, Subunit--administration & dosage